Loading
Immgenuity has a live attenuated therapeutic vaccine for treatment of HIV infection. Our vaccine will play a major role in structured therapeutic interruptions of cARV. Our vaccine will very likely be effective in the central nervous system which is a highly conserved sanctuary region. A therapeutic vaccine will reduce drug induced toxicity during the therapeutic interruptions and promote replicative incompetence. This in turn will reduce comorbidities and help attain remission.
"Immgenuity's therapeutic vaccine will be particularly useful in addressing HIV related nervous system conditions such as HAND and HAD."

Therapeutic vaccines are coming of age in the treatment of HIV infection. They are particularly useful in structured therapeutic interruptions and to generate viral suppression in highly conserved sanctuary areas such as the brain. In addition to helping patients with HAND, using a therapeutic vaccine has the potential to help with hepatotoxicity and nephrotoxicity associated with long term ARV use.

Our therapeutic vaccine adds to the current arsenal of antiretroviral therapy by reaching sanctuaries where ART is not as effective such as the central nervous system.

Therapeutic Vaccine

Therapeutic Vaccine is useful for Therapeutic vaccines are a new form of vaccines that are mostly.

Therapeutic Vaccine

Read More

NeuroHIV

The long-term health prognosis of aging with controlled HIV infection remains unclear especially in regard to HIV-associated neurocognitive disorder (HAND)

NeuroHIV

Read More